Showing results (201-210 of 480) with videos related to
Sort By:
Pageof 48
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 23, 2024
Donor and recipient genetics: Implications for the development of posttransplant diabetes mellitusOren Shaked, Bao-Li Loza, Kim M Olthoff, et al.Journal of the American Society of Nephrology : JASN|May 7, 2011
Effect of kidney transplantation on outcomes among patients with hepatitis CDavid Roth, Jeffrey J Gaynor, K Rajender Reddy, et al.Journal of Clinical Gastroenterology|April 1, 1986
The unusual presentation of "large" gallstones. The diagnostic role of endoscopyK Rajender Reddy, J B Raskin, H D Manten, et al.Clinical Transplantation|November 17, 2010
Clinical outcomes of liver transplantation for HBV-related hepatocellular carcinoma: data from the NIH HBV OLT studySteven-Huy Han, K Rajender Reddy, Emmet B Keeffe, et al.Hepatology (Baltimore, Md.)|August 19, 2005
Quality of life in refractory ascites: transjugular intrahepatic portal-systemic shunting versus medical therapyMical S Campbell, Colleen M Brensinger, Arun J Sanyal, et al.Nucleosides, Nucleotides & Nucleic Acids|January 28, 2020
Synthesis, structural characterization, in vitro DNA binding, and antitumor activity properties of Ru(II) compounds containing 2(2,6-dimethoxypyridine-3-yl)-1H-imidazo(4,5-f)[1, 10]phenanthrolineNagamani Chintakuntla, Venkat Reddy Putta, Rajender Reddy Mallepally, et al.Dalton Transactions (Cambridge, England : 2003)|January 8, 2014
An unexpected semi-hydrogenation of a ligand in the complexation of 2,7-bispyridinyl-1,8-naphthyridine with Ru3(CO)12Bei-Sih Liao, Yi-Hung Liu, Shie-Ming Peng, et al.Hepatology (Baltimore, Md.)|September 29, 2006
Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current managementStephen H Caldwell, Maureane Hoffman, Ton Lisman, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 2, 2007
Impact of ribavirin dose reductions in hepatitis C virus genotype 1 patients completing peginterferon alfa-2a/ribavirin treatmentK Rajender Reddy, Mitchell L Shiffman, Timothy R Morgan, et al.Journal of Fluorescence|December 25, 2010
Synthesis, characterization luminiscence studies and microbial activity of ethylenediamine ruthenium (II) complexes with dipyridophenazine ligandsMynam Shilpa, Penumaka Nagababu, Y Praveen Kumar, et al.Pageof 48